Raymond Houghton
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1996First federal award
$2.6MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $2.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 1, 1998 | NIH | SBIR/STTR Phase II NOVEL ANTIGENS FOR THE SERODIAGNOSIS OF HUMAN BABESIOSIS | $135K | — |
| Mar 1, 1998 | NIH | SBIR/STTR Phase II NOVEL ANTIGENS FOR THE SERODIAGNOSIS OF HUMAN BABESIOSIS | $377K | — |
| Mar 1, 1998 | NIH | SBIR/STTR Phase II NOVEL ANTIGENS FOR THE SERODIAGNOSIS OF HUMAN BABESIOSIS | $368K | — |
| Sep 30, 1997 | NIH | SBIR/STTR Phase I NOVEL ANTIGENS FOR THE SERODIAGNOSIS OF HUMAN BABESIOSIS | $100K | — |
| Sep 30, 1997 | NIH | SBIR/STTR Phase II NOVEL GENES FOR THE DIAGNOSIS/PROGNOSIS OF BREAST CANCER | $382K | — |
| Sep 30, 1997 | NIH | SBIR/STTR Phase II NOVEL GENES FOR THE DIAGNOSIS/PROGNOSIS OF BREAST CANCER | $385K | — |
| Apr 15, 1996 | NIH | SBIR/STTR Phase I NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSIS | $100K | — |
| Apr 15, 1996 | NIH | SBIR/STTR Phase II NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSIS | $361K | — |
| Apr 15, 1996 | NIH | SBIR/STTR Phase II NOVEL ANTIGENS FOR USE IN SERODIAGNOSIS OF TUBERCULOSIS | $389K | — |
Peer ranks
Federal funding#168
Awards as PI#67
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.